JM
Jan Moller Mikkelsen at Ascendis Pharma (NAS: ASND)
Developer of pro-drug technology for endocrinology, cardiovascular and central nervous system disorders
ContactFirm
Ascendis Pharma (NAS: ASND)
Location
Global
Investment Stage
Growth
Geographic Focus
Global
About Jan Moller Mikkelsen
Enriching content...
Similar Investors in Global
Contact Ascendis Pharma (NAS: ASND)
Get in touch for investment criteria and partnership opportunities.
Contact